China will expand its visa-free policy to include Japan, Bulgaria, Romania, Croatia, Montenegro, and other nations from November 30, 2024, to December 31, 2025. The country will also extend the visa-free stay period for all 38 participating countries from 15 to 30 days to boost tourism and trade.
China will expand its visa-free policy to include Japan, Bulgaria, Romania, Croatia, Montenegro, and other countries, starting from November 30, 2024, and lasting until December 31, 2025. This announcement was made by a foreign ministry spokesperson on Friday.
In addition to this expansion, China will also extend the visa-free stay period for citizens of all 38 countries included in its current visa-free program. The new stay period will be increased from 15 days to 30 days, according to state television CCTV.
This move follows China’s earlier visa-free arrangements with South Korea and several European countries, as part of efforts to boost tourism and trade amidst a sluggish economy.
Read next
18:00
China - US
Stephen Orlins, president of the National Committee on United States-China Relations (NCUSCR), stated that China and the United States should cooperate in the field of artificial intelligence (AI) to avoid duplicating efforts.
13:00
Japan
Japan has lodged an official protest with China over a statement that it claims misquoted Prime Minister Shigeru Ishiba’s comments during his meeting with Chinese Foreign Minister Wang Yi on Friday. Japan’s top government spokesperson confirmed the protest on Monday.
12:30
China
China is working to reassure top U.S. corporate leaders about its strong business potential amid ongoing geopolitical tensions and a slowing domestic economy.
14:30
Tencent
Chinese tech giant Tencent on Friday night launched the official version of its T1 reasoning model, marking a significant step in its bid to strengthen its foothold in the rapidly evolving artificial intelligence landscape.
12:15
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
What is your opinion on this topic?
Leave the first comment